Skip to main content

Table 2 Overall survival analysis in AIS patients and subgroups

From: Detection of E2A-PBX1 fusion transcripts in human non-small-cell lung cancer

Group Gender E2A-PBX1 status Patient number Median survival (months) 95% CI P value
AIS patients Female   53 105.60 63.95 ~ 147.25 0.0378
  Male   23 56.20 22.34 ~ 90.06  
AIS patients with E2A-PBX1 Female   12 56.20 37.46 ~ 74.94 0.6401
  Male   5 56.20 0.00 ~ 122.80  
AIS patients without E2A-PBX1 Female   41 105.60 63.45 ~ 147.75 0.0345
  Male   18 NR NA  
AIS patients   + 17 56.20 44.37 ~ 68.03 0.1235
   - 59 105.60 63.95 ~ 147.25  
AIS stage I patients   + 10 56.20 38.38 ~ 74.02 0.1753
   - 41 105.60 63.65 ~ 147.55  
AIS female patients   + 12 56.20 37.46 ~ 74.94 0.0747
   - 41 105.60 63.45 ~ 147.75  
AIS stage IA patients   + 6 NR NA 0.0363
   - 18 NR NA  
AIS stage IA female patients   + 4 46.70 8.77 ~ 84.63 0.0174
   - 13 105.60 NA  
  1. NR: not reached; NA: not available.